🔎 Trials Near Me

홈 › 흑색종 › 뉴욕 › New York City

NY New York City의 흑색종 임상 시험

흑색종 관련 연구 38개가 New York City 및 인근(약 30마일 이내) 지역에서 참여자를 모집하고 있습니다. 연구 항목을 열어 참여 자격 및 연구 팀 연락처를 확인하세요.

공식 연구 텍스트(영어)

연구 대상자를 모집 중이신가요? 이 페이지 상단에 노출하세요 — 30일 동안 $99 →

Safety and Efficacy of OBX-115 in Advanced Solid Tumors

피험자 모집 중1/2상
  • Memorial Sloan Kettering (Melanoma/NSCLC), New York
18세 이상 · 모든 성별 · 2026. 10. 5. 업데이트됨 · NCT06060613

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

피험자 모집 중관찰 연구건강한 지원자 환영
  • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
40세 ~ 75세 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT05334069

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

피험자 모집 중2상
  • Memorial Sloan Kettering Hospital, New York
18세 이상 · 모든 성별 · 2026. 10. 1. 업데이트됨 · NCT06172478

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

피험자 모집 중2상
  • Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT05136196

Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma

피험자 모집 중3상
  • Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
75세 이상 · 모든 성별 · 2026. 9. 24. 업데이트됨 · NCT07068074

Bright Light Therapy in Patients With Melanoma or Non-small Cell Lung Cancer (NSCLC) Who Are Receiving First-Line Immune Checkpoint Blockade

피험자 모집 중
  • Weill Cornell Medicine, New York
18세 이상 · 모든 성별 · 2026. 9. 23. 업데이트됨 · NCT07661966

BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)

피험자 모집 중1/2상
  • Memorial Sloan Kettering Cancer Center, New York
18세 이상 · 모든 성별 · 2026. 9. 18. 업데이트됨 · NCT04752826

A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)

피험자 모집 중2상
  • Local Institution - 0170, New York
  • Memorial Sloan Kettering Cancer Center, New York
18세 이상 · 모든 성별 · 2026. 9. 16. 업데이트됨 · NCT07492680

A Study of LN-144 or LN-145 in People With Advanced Uveal Melanoma, Undifferentiated Pleomorphic Sarcoma, Dedifferentiated Liposarcoma, or Angiosarcoma

피험자 모집 중1상
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
18세 이상 · 모든 성별 · 2026. 9. 15. 업데이트됨 · NCT05607095

A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors

피험자 모집 중1상
  • NYU Langone, New York
18세 이상 · 모든 성별 · 2026. 9. 2. 업데이트됨 · NCT04913285

A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors

피험자 모집 중1/2상
  • Memorial Sloan Kettering Hospital, New York
18세 이상 · 모든 성별 · 2026. 9. 2. 업데이트됨 · NCT07070232

Study of the Efficacy of Intratumoral L19IL2 or L19TNF or L19IL2/L19TNF, in Combination With Pembrolizumab, in Unresectable Melanoma Patients

피험자 모집 중2상
  • Memorial Sloan Kettering Cancer Center, New York
18세 이상 · 모든 성별 · 2026. 9. 2. 업데이트됨 · NCT06284590

A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue

피험자 모집 중
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
18세 이상 · 모든 성별 · 2026. 9. 2. 업데이트됨 · NCT05837767

Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer

피험자 모집 중1/2상
  • Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
18세 이상 · 모든 성별 · 2026. 8. 31. 업데이트됨 · NCT05896839

Project: Every Child for Younger Patients With Cancer

피험자 모집 중관찰 연구
  • Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
  • Mount Sinai Hospital, New York
  • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
  • 외 2개
25세 이하 · 모든 성별 · 2026. 8. 25. 업데이트됨 · NCT02402244

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

피험자 모집 중1/2상
  • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
12 Months – 30 Years · 모든 성별 · 2026. 8. 25. 업데이트됨 · NCT04851119

ctDNA-guided Addition of Ipilimumab to Patients Receiving Nivolumab and Relatlimab

피험자 모집 중2상
  • NYU Langone Health, New York
18세 이상 · 모든 성별 · 2026. 8. 24. 업데이트됨 · NCT07504796

Safety and Tolerability Study of GIM-531 in Advanced Solid Tumors

피험자 모집 중1/2상
  • Weill Cornell Medicine - New York Presbyterian Hospital, New York
18세 이상 · 모든 성별 · 2026. 8. 14. 업데이트됨 · NCT06425926

A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer

피험자 모집 중1상
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
18세 이상 · 모든 성별 · 2026. 8. 12. 업데이트됨 · NCT05859074

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

피험자 모집 중1/2상
  • NYU Langone Health, New York
  • Icahn School of Medicine At Mount Sinai Prime, New York
18세 이상 · 모든 성별 · 2026. 8. 5. 업데이트됨 · NCT06330064

A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)

피험자 모집 중1/2상
  • Call for Information (Investigational Site 0031), New York
6 Months – 17 Years · 모든 성별 · 2026. 7. 6. 업데이트됨 · NCT02332668

A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer

피험자 모집 중1/2상
  • Weill Medical College of Cornell University, New York
  • Memorial Sloan Kettering Cancer Center, New York
18세 ~ 70세 · 모든 성별 · 2026. 6. 11. 업데이트됨 · NCT05361174

DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors

피험자 모집 중2상
  • USA04-0, New York
18세 이상 · 모든 성별 · 2026. 5. 22. 업데이트됨 · NCT06953089

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

피험자 모집 중1/2상
  • Perlmutter Cancer Center at NYU Langone Health, New York
  • Memorial Sloan-Kettering Cancer Center, New York
  • Columbia University, New York
18세 이상 · 모든 성별 · 2026. 5. 15. 업데이트됨 · NCT05379985

ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors

피험자 모집 중1/2상
  • Memorial Sloan Kettering Cancer Center, New York
18세 이상 · 모든 성별 · 2026. 5. 13. 업데이트됨 · NCT03686124

Neoadjuvant Darovasertib in Primary Uveal Melanoma

피험자 모집 중3상
  • Herbert Irving Comprehensive Cancer Center, New York
  • Memorial Sloan Kettering Cancer Center - 1275 York Ave, New York
  • Northwell Health Cancer Institute, New York
18세 이상 · 모든 성별 · 2026. 5. 6. 업데이트됨 · NCT07015190

A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors

피험자 모집 중1상
  • Laura & Isaac Perlmutter Cancer Center at NYU Langone Health, New York
  • Columbia University Medical Center, New York
  • Memorial Slone Kettering Cancer Center, New York
18세 이상 · 모든 성별 · 2026. 4. 20. 업데이트됨 · NCT06326411

A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma

피험자 모집 중2/3상
  • Memorial Sloan Kettering Cancer Center, New York
전 연령 · 모든 성별 · 2026. 4. 2. 업데이트됨 · NCT06581406

Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)

피험자 모집 중3상
  • Memorial Sloan Kettering Cancer Center, New York
18세 이상 · 모든 성별 · 2026. 2. 25. 업데이트됨 · NCT05549297

ACTengine® IMA203 Combined With mRNA-4203

피험자 모집 중1상
  • Memorial Sloan Kettering Cancer Center, New York
18세 이상 · 모든 성별 · 2026. 1. 8. 업데이트됨 · NCT06946225

Interleukin-6 Receptor Inhibitor Sarilumab in Combination With Ipilimumab, Nivolumab and Relatlimab in Patients With Unresectable Stage III or Stage IV Melanoma

피험자 모집 중2상
  • NYU Langone Health, New York
18세 ~ 100세 · 모든 성별 · 2026. 1. 5. 업데이트됨 · NCT05428007

A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

피험자 모집 중1/2상
  • Research Site 107, New York
18세 이상 · 모든 성별 · 2025. 11. 21. 업데이트됨 · NCT05914116

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

피험자 모집 중관찰 연구
  • Massive Bio SYNERGY-AI site, New York
전 연령 · 모든 성별 · 2025. 10. 28. 업데이트됨 · NCT03452774

Excision of Lymph Node Trial (EXCILYNT) (Mel69)

피험자 모집 중
  • Memorial Sloan Kettering Cancer Center, New York
18세 이상 · 모든 성별 · 2025. 9. 17. 업데이트됨 · NCT05839912

A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors

피험자 모집 중1/2상
  • Weill Cornell Medicine-New York-Presbyterian Hospital, New York
18세 이상 · 모든 성별 · 2025. 5. 18. 업데이트됨 · NCT05970497

A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies

피험자 모집 중1/2상
  • NYU Langone Health, New York
18세 이상 · 모든 성별 · 2025. 2. 13. 업데이트됨 · NCT05669430

Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

피험자 모집 중
  • Laura & Isaac Perlmutter Cancer Center at NYU Langone Health, New York
  • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
  • Memorial Sloan Kettering Cancer Center, New York
18세 이상 · 모든 성별 · 2024. 11. 27. 업데이트됨 · NCT03860883

A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)

피험자 모집 중1/2상
  • Memorial Sloan-Kettering Cancer Center, New York
18세 이상 · 모든 성별 · 2024. 11. 25. 업데이트됨 · NCT05824975

다른 도시의 흑색종 시험

New York City의 다른 연구

ClinicalTrials.gov 출처, 2026. 10. 6. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.